how does glp 1 affect the brain GLP-1 for Weight Loss and Diabetes Glp-1 drugs offer brain benefits

Freshly Uncovered News and Studies In July 2023, a wave of stories emerged shedding light on the challenges faced by individuals using Ozempic and Wegovy who were later diagnosed with gastroparesis

Tirzepatide injection specifics Tirzepatide is a dual GIP/GLP-1 receptor agonist, meaning it activates two incretin pathways rather than one

Our 2025 study in JMIR Formative Research examined 12-month outcomes for participants using semaglutide with behavioural support and found 1 : 19.1% average weight loss at 12 months for active subscribers 77.7% achieved at least 10% weight loss 61.5% achieved at least 15% weight loss 69% reported no side effects by month 12 These are completer results (people who stayed on the programme for 12 months), not intent-to-treat

However, they need further evidence-based studies

These reports can show possible safety signals, but they do not prove that a drug caused a specific injury in every case